Wed, May 26, 2010
Tue, May 25, 2010
Mon, May 24, 2010
Fri, May 21, 2010
Thu, May 20, 2010
Wed, May 19, 2010
Tue, May 18, 2010
Mon, May 17, 2010
Sun, May 16, 2010
Sat, May 15, 2010
Fri, May 14, 2010
Thu, May 13, 2010

Spectranetics to Present at the Citi Global Health Care Conference on May 27


//health-fitness.news-articles.net/content/2010/ .. iti-global-health-care-conference-on-may-27.html
Published in Health and Fitness on Thursday, May 20th 2010 at 4:10 GMT by Market Wire   Print publication without navigation


COLORADO SPRINGS, Colo.--([ BUSINESS WIRE ])--Spectranetics Corporation (Nasdaq:SPNC) today announced it will present at the Citi Global Health Care Conference being held May 26-27, 2010 at the Hilton New York Hotel in New York City.

Guy A. Childs, Spectraneticsa™ chief financial officer, is scheduled to speak on Thursday, May 27 at 9:30 a.m. Eastern time (7:30 a.m. Mountain time) and will discuss the Company's growth drivers and market opportunities.

Interested parties can access a live audio webcast and slide presentation at [ www.spectranetics.com ]. An archived presentation will be available on the Web site for 14 days.

About Spectranetics

Spectranetics develops, manufactures, markets and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system. The Companya™s products are sold in 40 countries throughout the world and are used to treat arterial blockages in the heart and legs as well as the removal of problematic pacemaker and defibrillator leads.

The Companya™s Vascular Intervention (VI) products include a range of peripheral and cardiac laser catheters for ablation of occluded arteries above and below the knee and within coronary arteries. The Company also markets aspiration and thrombectomy catheters for the removal of thrombus and support catheters to facilitate crossing of coronary and peripheral arterial blockages.

The Lead Management (LM) product line includes excimer laser sheaths and cardiac lead management accessories for the removal of problematic pacemaker and defibrillator cardiac leads.

For more information, visit [ www.spectranetics.com ].


Publication Contributing Sources